Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

NCT01947907 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency (GHD)

Interventions

DRUG: ACP-001
DRUG: Human Growth Hormone

Sponsor

Ascendis Pharma A/S